CorVista Raises Equity Capital
TM Capital advised CorVista Health, Inc. in raising $65 million of Series C equity capital to advance its artificial intelligence-based cardiovascular diagnostic technology
SteriGenics Acquired by IBA
TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash
Time-Cap Labs Acquired by Marksans Pharma
TM Capital served as exclusive financial advisor to founder-owned Time-Cap Labs, Inc. in its sale to Marksans Pharma Limited (BSE:524404), headquartered in Mumbai, India
Empirical Bioscience has been Acquired by Fortis Life Sciences
TM Capital, together with Pegasus Capital, served as a financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences
SHPl Acquires The Med-Design Corporation
TM Capital advised Specialized Health Products International, Inc. (OTC: SHPI) in its acquisition of The Med-Design Corporation (NASDAQ: MEDC)